VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF) , a clinical-stage biotech company dedicated to developing neurorestorative ...
As the research indicates, organizations that invest in upskilling activities and create clear governance structures for AI see adoption rates 3.5 times higher than those focusing solely on ...